NIH Mission and Strategic Goals
The National Institutes of Health operates under a statutory mission that shapes how billions of federal research dollars are allocated each year. This page explains the formal mission statement, how it translates into strategic goals, the mechanisms by which those goals are operationalized across NIH's 27 institutes and centers, and how strategic boundaries are drawn when priorities compete. Understanding the mission framework is essential for researchers, policymakers, and institutions seeking to align their work with federally funded science.
Definition and scope
The NIH mission, as stated in the Public Health Service Act (42 U.S.C. § 241), is "to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability." This formulation establishes two parallel imperatives: basic science discovery and translational application. Neither strand can be sacrificed for the other without diverging from the statutory mandate.
The scope of the mission extends across the full biomedical and behavioral research enterprise. The NIH Strategic Plan, updated on a roughly 5-year cycle, translates this broad mandate into operational objectives organized around four overarching goals:
- Advancing biomedical research opportunities — supporting discovery across basic, translational, and clinical domains.
- Fostering innovation through a stable and diverse research workforce — addressing pipeline, training, and equity dimensions.
- Enhancing science for the benefit of society — expanding access to findings and ensuring ethical conduct.
- Excelling as a federal science agency — maintaining stewardship of the approximately $47 billion annual budget (NIH Budget, FY2023, Office of Budget).
These four goals are not independent pillars; they interact. Workforce investment (Goal 2) directly enables discovery output (Goal 1), while stewardship standards (Goal 4) condition whether societal benefit (Goal 3) is credibly delivered.
The NIH home resource at /index provides orientation to the broader institutional structure within which mission execution occurs.
How it works
Strategic goal translation at NIH operates through a layered governance structure. The Office of the Director sets agencywide priorities, which are then interpreted by each institute and center through institute-specific strategic plans. The National Cancer Institute, for example, publishes its own strategic plan that nests within the NIH-wide framework while addressing cancer-specific research priorities. This dual-layer architecture — agencywide plus institute-level — allows mission coherence while permitting scientific specialization.
Budget allocation is the primary enforcement mechanism. The NIH budget process ties funding distributions to strategic priorities through the congressional appropriations process. Program announcements, Requests for Applications (RFAs), and set-aside funding streams are all instruments by which strategic goals are converted into funded research activity. An RFA signals that a strategic gap has been identified and that NIH is directing investigator attention toward it, rather than waiting for investigator-initiated proposals to fill it organically.
The NIH peer review process also reflects mission priorities. Study sections evaluate scientific merit independently, but the secondary review layer — carried out by institute advisory councils — applies program relevance criteria that reflect strategic goals. A grant that scores well on scientific merit but falls outside an institute's current strategic focus may not receive funding, demonstrating that mission alignment functions as a binding constraint, not merely an aspiration.
NIH research priorities and initiatives documents how specific programs such as the BRAIN Initiative and the All of Us Research Program emerge as mission-aligned investments that represent concentrated strategic commitments.
Common scenarios
Three recurring situations illustrate how the NIH mission and strategic goals interact with real funding and research decisions.
Basic vs. translational priority tension. An investigator submitting a purely mechanistic biochemistry proposal may encounter a study section enthusiastic about the science but an institute advisory council less certain of near-term translational relevance. The NIH-wide strategic plan explicitly recognizes both modes of research as mission-critical, but individual institutes weight them differently. The National Institute on Aging, for instance, allocates resources across basic neuroscience and clinical dementia trials, while the relative weighting shifts with each strategic plan revision.
Workforce and diversity goals intersecting with grant programs. NIH's commitment to a stable and diverse workforce — Goal 2 in the strategic plan — generates specific funding mechanisms: the Research Supplements to Promote Diversity in Health-Related Research, and the NIH Diversity, Equity, and Inclusion in Research initiatives. Investigators at institutions with strong existing grant portfolios compete differently from those at Institutional Development Award (IDeA)-eligible states, where geographic diversity criteria apply.
Emergency response reorientation. When Congress or the executive branch directs NIH to redirect resources toward an urgent public health need, the mission framework provides the authority basis while the NIH role in US public health emergency response page describes operational mechanisms. The statutory mission's breadth — "reduce illness and disability" — accommodates rapid reorientation without requiring legislative amendment.
Decision boundaries
The NIH mission draws several meaningful boundaries that constrain what NIH funds and how.
Intramural vs. extramural scope. The mission applies equally to intramural and extramural research, but strategic goals are pursued differently in each context. Intramural programs — conducted at NIH's own campuses — can absorb higher-risk, longer-horizon projects because they are not subject to the grant renewal cycle. Extramural funding, which constitutes approximately 80 percent of the NIH budget, must remain accountable to peer review standards and institute program priorities.
Biomedical scope vs. health services research. NIH's mission centers on biological and behavioral mechanisms, not health system delivery or insurance policy. The Agency for Healthcare Research and Quality (AHRQ) holds primary jurisdiction over health services and delivery research. NIH-funded projects that drift toward pure health economics without a biomedical anchor may be redirected to AHRQ or deemed outside NIH's core mission scope.
Applied research ceilings. NIH does not fund product commercialization. The Small Business Innovation Research and Small Business Technology Transfer programs fund feasibility and early development but stop at the threshold of commercial production. This boundary distinguishes NIH's mission from the Department of Defense or Department of Energy applied technology programs, which extend further toward deployment.
NIH policies and regulations and NIH congressional oversight and authorization provide the statutory and regulatory scaffolding within which these decision boundaries are enforced.